Top compounds associated with response to LUZP6


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K78574327 CTRPv2 pan-cancer AAC 0.13 0.1
mRNA tigecycline CTRPv2 pan-cancer AAC 0.083 0.1
mRNA momelotinib CTRPv2 pan-cancer AAC -0.061 0.1
mRNA Zebularine CTRPv2 pan-cancer AAC -0.06 0.1
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.1
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.078 0.1
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC -0.065 0.1
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.1
mRNA KPT185 CTRPv2 pan-cancer AAC -0.067 0.1
Download CSV